Table III.
Changes in diastolic BP measured over the 12-week treatment and 4-week post-treatment follow-up periods in prehypertensive and mildly hypertensive subjects.
| Prehypertensive
|
Mildly hypertensive
|
|||
|---|---|---|---|---|
| Time | Placebo group (n=17) | GH group (n=15) | Placebo group (n=21) | GH group (n=19) |
| Baseline | 82.0±1.1 | 82.6±1.7 | 91.2±1.3 | 90.2±1.6 |
| Week 4 | 80.1±1.3 | 81.2±1.3 | 90.6±1.3 | 86.3±1.5a |
| Week 8 | 79.7±2.0 | 80.9±1.4 | 91.0±1.6 | 85.0±1.0b |
| Week 12 | 81.2±1.6 | 80.9±1.6 | 90.8±1.6 | 85.6±1.5b |
| Post-week 4 | 78.7±1.8 | 82.3±1.7 | 91.2±1.6 | 86.0±1.6 |
Values are the mean ± standard error of the mean (SEM). Baseline values were determined immediately prior to the start of treatment.
a
P<0.05,
b
P<0.01 against baseline (within-group differences in measurement). GH, garlic homogenate-based supplementary diet; BP, blood pressure.